Ingo Langner

1.4k total citations
45 papers, 1.1k citations indexed

About

Ingo Langner is a scholar working on Psychiatry and Mental health, Health, Toxicology and Mutagenesis and Epidemiology. According to data from OpenAlex, Ingo Langner has authored 45 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Psychiatry and Mental health, 9 papers in Health, Toxicology and Mutagenesis and 9 papers in Epidemiology. Recurrent topics in Ingo Langner's work include Air Quality and Health Impacts (8 papers), Chronic Disease Management Strategies (8 papers) and Attention Deficit Hyperactivity Disorder (8 papers). Ingo Langner is often cited by papers focused on Air Quality and Health Impacts (8 papers), Chronic Disease Management Strategies (8 papers) and Attention Deficit Hyperactivity Disorder (8 papers). Ingo Langner collaborates with scholars based in Germany, Denmark and Greece. Ingo Langner's co-authors include Edeltraut Garbe, Hajo Zeeb, Maria Blettner, Rafael Mikolajczyk, Gaël P. Hammer, Oliver Riedel, Christina Lindemann, Tobias Banaschewski, Ulrike Petermann and Franz Petermann and has published in prestigious journals such as PLoS ONE, Biometrics and Journal of Clinical Epidemiology.

In The Last Decade

Ingo Langner

44 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ingo Langner Germany 19 238 194 165 161 115 45 1.1k
Pablo Emilio Verde Germany 26 102 0.4× 190 1.0× 160 1.0× 90 0.6× 56 0.5× 82 1.9k
Jaakko Nevalainen Finland 26 104 0.4× 208 1.1× 299 1.8× 119 0.7× 165 1.4× 128 2.6k
Mounir Mesbah France 19 78 0.3× 188 1.0× 98 0.6× 92 0.6× 36 0.3× 62 1.5k
Jonathan French United States 21 218 0.9× 73 0.4× 78 0.5× 48 0.3× 240 2.1× 74 2.0k
P Silcocks United Kingdom 20 144 0.6× 214 1.1× 186 1.1× 41 0.3× 40 0.3× 41 1.5k
Erik Sauleau France 24 70 0.3× 46 0.2× 300 1.8× 97 0.6× 126 1.1× 107 1.7k
Jamie C. Sergeant United Kingdom 25 59 0.2× 119 0.6× 241 1.5× 56 0.3× 33 0.3× 79 1.6k
A.L.M. Verbeek Netherlands 26 269 1.1× 290 1.5× 369 2.2× 60 0.4× 61 0.5× 62 3.0k
Seyed Ehsan Saffari Singapore 20 129 0.5× 99 0.5× 112 0.7× 20 0.1× 82 0.7× 158 1.5k
Ghada Abo-Zaid United Kingdom 7 92 0.4× 38 0.2× 121 0.7× 54 0.3× 76 0.7× 11 1.4k

Countries citing papers authored by Ingo Langner

Since Specialization
Citations

This map shows the geographic impact of Ingo Langner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingo Langner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingo Langner more than expected).

Fields of papers citing papers by Ingo Langner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingo Langner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingo Langner. The network helps show where Ingo Langner may publish in the future.

Co-authorship network of co-authors of Ingo Langner

This figure shows the co-authorship network connecting the top 25 collaborators of Ingo Langner. A scholar is included among the top collaborators of Ingo Langner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingo Langner. Ingo Langner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Langner, Ingo, et al.. (2023). German mammography screening program: program sensitivity between 2010 and 2016 estimated based on German health claims data. BMC Cancer. 23(1). 852–852. 2 indexed citations
3.
Riedel, Oliver, et al.. (2022). Stability of individual dementia diagnoses in routine care: Implications for epidemiological studies. Pharmacoepidemiology and Drug Safety. 31(5). 546–555. 3 indexed citations
4.
Kollhorst, Bianca, Ingo Langner, Heike Minnerup, et al.. (2022). Effectiveness of Mammography Screening on Breast Cancer Mortality – A Study Protocol for Emulation of Target Trials Using German Health Claims Data. Clinical Epidemiology. Volume 14. 1293–1303. 3 indexed citations
5.
Riedel, Oliver, et al.. (2022). Dementia in health claims data: The influence of different case definitions on incidence and prevalence estimates. International Journal of Methods in Psychiatric Research. 32(2). 67–88. 6 indexed citations
6.
Riedel, Oliver, et al.. (2021). Prevalence of multimodal treatment in children and adolescents with ADHD in Germany: a nationwide study based on health insurance data. Child and Adolescent Psychiatry and Mental Health. 15(1). 76–76. 4 indexed citations
7.
8.
Kieschke, Joachim, et al.. (2019). Assessing and Explaining Geographic Variations in Mammography Screening Participation and Breast Cancer Incidence. Frontiers in Oncology. 9. 909–909. 9 indexed citations
9.
Langner, Ingo, Christoph Ohlmeier, Hajo Zeeb, Ulrike Haug, & Oliver Riedel. (2019). Individual mortality information in the German Pharmacoepidemiological Research Database (GePaRD): a validation study using a record linkage with a large cancer registry. BMJ Open. 9(7). e028223–e028223. 16 indexed citations
10.
Giersiepen, Klaus, Ingo Langner, Heinz Rothgang, et al.. (2018). A cohort study of mammography screening finds that comorbidity measures are insufficient for controlling selection bias. Journal of Clinical Epidemiology. 104. 1–7. 3 indexed citations
11.
Mikolajczyk, Rafael, Niklas Schmedt, Jun Zhang, et al.. (2013). Regional variation in caesarean deliveries in Germany and its causes. BMC Pregnancy and Childbirth. 13(1). 99–99. 19 indexed citations
12.
Garbe, Edeltraut, Rafael Mikolajczyk, Tobias Banaschewski, et al.. (2012). Drug Treatment Patterns of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents in Germany: Results from a Large Population-Based Cohort Study. Journal of Child and Adolescent Psychopharmacology. 22(6). 452–458. 55 indexed citations
13.
Lindemann, Christina, Ingo Langner, Tobias Banaschewski, et al.. (2012). Age-Specific Prevalence, Incidence of New Diagnoses, and Drug Treatment of Attention-Deficit/Hyperactivity Disorder in Germany. Journal of Child and Adolescent Psychopharmacology. 22(4). 307–314. 37 indexed citations
14.
Hammer, Gaël P., Maria Blettner, Ingo Langner, & Hajo Zeeb. (2012). Cosmic radiation and mortality from cancer among male German airline pilots: extended cohort follow-up. European Journal of Epidemiology. 27(6). 419–429. 20 indexed citations
15.
Dörks, Michael, Ingo Langner, Antje Timmer, & Edeltraut Garbe. (2012). Treatment of paediatric epilepsy in Germany: Antiepileptic drug utilisation in children and adolescents with a focus on new antiepileptic drugs. Epilepsy Research. 103(1). 45–53. 25 indexed citations
16.
17.
Zeeb, Hajo, et al.. (2009). Cancer mortality among German aircrew: second follow-up. Radiation and Environmental Biophysics. 49(2). 187–194. 26 indexed citations
18.
Langner, Ingo, Maria Blettner, Maryanne Gundestrup, et al.. (2003). Cosmic radiation and cancer mortality among airline pilots: results from a European cohort study (ESCAPE). Radiation and Environmental Biophysics. 42(4). 247–256. 71 indexed citations
19.
Zeeb, Hajo, Ingo Langner, & Maria Blettner. (2003). Cardiovascular mortality of cockpit crew in Germany: cohort study. Zeitschrift für Kardiologie. 92(6). 483–489. 12 indexed citations
20.
Blettner, Maria, Hajo Zeeb, Anssi Auvinen, et al.. (2003). Mortality from cancer and other causes among male airline cockpit crew in Europe. International Journal of Cancer. 106(6). 946–952. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pablo Emilio Verde Breakdown of academic impact, for papers by Jaakko Nevalainen Breakdown of academic impact, for papers by Mounir Mesbah Breakdown of academic impact, for papers by Jonathan French Breakdown of academic impact, for papers by P Silcocks Breakdown of academic impact, for papers by Erik Sauleau Breakdown of academic impact, for papers by Jamie C. Sergeant Breakdown of academic impact, for papers by A.L.M. Verbeek Breakdown of academic impact, for papers by Seyed Ehsan Saffari Breakdown of academic impact, for papers by Ghada Abo-Zaid
Rankless by CCL
2026